LAI GOLDMAN MYLA — SEC Form 4 filings
SEC reporting owner CIK 1168581. 9 Form 4 filings on record with FilingPulse; latest filed 2026-07-09.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-04-25 to 2026-07-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Quanterix Corp (QTRX) | Director | 4 | — | — | 8 |
| Akoya Biosciences, Inc. (AKYA) | Director | 2 | — | — | 6 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | Director | 3 | — | — | 3 |
Form 4 filings — LAI GOLDMAN MYLA
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-09 | 4 | Quanterix Corp (QTRX) | Option exercise (M): 8,073 · Option exercise (M): 8,073 (derivative) @ $0 | EDGAR |
| 2026-05-06 | 4 | WEST PHARMACEUTICAL SERVICES INC (WST) | Grant/award (A): 791 @ $0 | EDGAR |
| 2026-01-06 | 4 | Quanterix Corp (QTRX) | Grant/award (A): 23,372 @ $0 · Grant/award (A): 1,944 @ $0 | EDGAR |
| 2025-10-03 | 4 | Quanterix Corp (QTRX) | Grant/award (A): 2,084 @ $5.54 | EDGAR |
| 2025-07-10 | 4 | Akoya Biosciences, Inc. (AKYA) | Other (J): 20,000 · Other (J): 38,993 (derivative) @ $0 · Other (J): 30,549 (derivative) @ $0 · Other (J): 56,322 (derivative) @ $0 · Other (J): 50,000 (derivative) @ $0 | EDGAR |
| 2025-07-10 | 4 | Quanterix Corp (QTRX) | Grant/award (A): 2,940 · Grant/award (A): 24,464 @ $0 · Grant/award (A): 50,758 (derivative) @ $0 | EDGAR |
| 2025-05-08 | 4 | WEST PHARMACEUTICAL SERVICES INC (WST) | Grant/award (A): 1,071 @ $0 | EDGAR |
| 2024-06-05 | 4 | Akoya Biosciences, Inc. (AKYA) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-04-25 | 4 | WEST PHARMACEUTICAL SERVICES INC (WST) | Grant/award (A): 564 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1168581 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →